Hangzhou Biotest Biotech Co.,Ltd.

SSE:688767.SS

32.14 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income 0017.03732.54439.63119.73829.92549.70311.899-111.843139.82252.438492.529114.48150.38335.577233.15478.93453.721266.5635.932
Depreciation & Amortization 0008.138.1329.173-14.257.2477.2476.6396.6395.026010.534-4.5444.54405.484-2.571.2851.285
Deferred Income Tax 000000000000000000000
Stock Based Compensation 000000000000000000-1.320.660.66
Change In Working Capital 00043.6310-25.24719.338-19.338058.904-21.46221.4620-111.19659.274-59.2740-127.94970.246-35.123-35.123
Accounts Receivables 00027.90-13.56928.457-28.4570107.835-62.45662.4560-51.429.454-29.4540-69.6223.272-11.636-11.636
Change In Inventory 00013.2890-14.143-9.1199.1190-48.93140.994-40.9940-60.84329.739-29.7390-60.89147.899-23.949-23.949
Change In Accounts Payables 0000002.907-2.9070-5.312-0.1950.195000000000
Other Working Capital 0002.44202.465-2.9072.90705.3120.195-0.19501.0480.081-0.08102.561-0.9250.4630.463
Other Non Cash Items 022.7453.47113.16316.893-19.73820.495-36.761-7.247-65.54314.823-26.488203.988-2.103-150.38-335.577-233.154-78.934-53.721-266.56-35.932
Operating Cash Flow 022.74520.50737.57756.52494.8955.5090.85211.899-111.843139.82252.438696.517112.1558.196437.408300.36991.57917.72168.383168.383
Investing Activities:
Investments In Property Plant And Equipment -9.967-12.784-50.429-13.659-168.183-42.989-1.76-2.518-9.157-25.841-14.334-102.417-36.327-55.489-83.146-38.366-21.957-18.806-9.385-14.746-14.746
Acquisitions Net 00000-3.994-04.1770.1350090000000000
Purchases Of Investments -1,639.125-3,344.951-2,373.224-1,275.600.004-3.304-107.667-0.500-2900-3200000000
Sales Maturities Of Investments 2,198.7592,787.8922,425.5191,175.610.01510.15920.389103.4910.365276.26383.989200000000000
Other Investing Activites -00.081-4.119-98.5310.01510.345-0103.491-0.1350-0-84.62100.227-80-39.606-21.9570.68650.13-64.376-14.326
Investing Cash Flow 549.667-569.762-2.253-113.659-158.168-32.64315.325100.973-9.292250.42269.655-187.038-36.327-375.262-163.146-39.606-21.957-18.1240.745-64.376-14.326
Financing Activities:
Debt Repayment 00.141-0.223000.409-0.3720.20300.0540-0.435-5-5.440.22303.0627.003-0.24100
Common Stock Issued 0000000000000856.1450000000
Common Stock Repurchased 0085-850-14.764000000000000000
Dividends Paid -53.208-1.7090-81.9360-234.667-8.696-225.970-320-12.724-307.276-0.011-0.068-0.138-0.138-20.568-0.087-99.609-0.343-0.343
Other Financing Activities 024.21-43.614-127.682-40.676-12.853-4.73-222.488-0.669.229-13.835-2.656-0-11.066850.252-1.78-0-3.530-34.4315.972
Financing Cash Flow -53.20822.64241.163-127.682-40.676-12.444-13.798-222.285-0.669.283-26.559-310.367-5.011-16.574849.098-1.78-17.5063.386-99.85-34.4315.972
Other Information:
Effect Of Forex Changes On Cash -0.4321.192-14.9283.4420.794-8.191-3.99837.584-14.501-17.61758.82668.692-4.995-11.3773.14-8.0261.44-9.053-10.2120.7810.781
Net Change In Cash 523.602-506.12144.49-200.309-141.52641.61253.037-82.877-44.515114.893107.988-300.888650.183-291.063747.287-41.386-39.46467.792-51.597-98.807-8.354
Cash At End Of Period 1,627.3621,103.7591,610.0851,565.5961,765.7131,907.2391,865.6261,812.5891,895.4661,939.7891,824.8961,716.9082,017.7951,367.6121,658.675911.388523.392261.047193.255244.85182.697